TR201203083A2 - Pharmaceutical dosage form comprising cefdinir and clavulanic acid. - Google Patents

Pharmaceutical dosage form comprising cefdinir and clavulanic acid.

Info

Publication number
TR201203083A2
TR201203083A2 TR2012/03083A TR201203083A TR201203083A2 TR 201203083 A2 TR201203083 A2 TR 201203083A2 TR 2012/03083 A TR2012/03083 A TR 2012/03083A TR 201203083 A TR201203083 A TR 201203083A TR 201203083 A2 TR201203083 A2 TR 201203083A2
Authority
TR
Turkey
Prior art keywords
cefdinir
clavulanic acid
dosage form
pharmaceutical dosage
clavulanic
Prior art date
Application number
TR2012/03083A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/03083A priority Critical patent/TR201203083A2/en
Publication of TR201203083A2 publication Critical patent/TR201203083A2/en

Links

Landscapes

  • Cephalosporin Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefdinir ve klavulanik asit ve/veya türevlerini içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions comprising cefdinir and clavulanic acid and / or derivatives as the active agent.

TR2012/03083A 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefdinir and clavulanic acid. TR201203083A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/03083A TR201203083A2 (en) 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefdinir and clavulanic acid.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/03083A TR201203083A2 (en) 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefdinir and clavulanic acid.

Publications (1)

Publication Number Publication Date
TR201203083A2 true TR201203083A2 (en) 2012-07-23

Family

ID=47004352

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/03083A TR201203083A2 (en) 2010-05-14 2010-05-14 Pharmaceutical dosage form comprising cefdinir and clavulanic acid.

Country Status (1)

Country Link
TR (1) TR201203083A2 (en)

Similar Documents

Publication Publication Date Title
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
CO6680667A2 (en) Ester derivatives of cyclic boronic acid and its therapeutic uses
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
MX2013001677A (en) Stable formulations of linaclotide.
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
UA115357C2 (en) Pyridin-4-yl derivatives
EA201400822A1 (en) DERIVATIVES OF HETEROCYCLIC AMIDES AS AN ANTAGONISTS OF P2HRECEPTOR
TR201009394A2 (en) Improved montelukast formulations.
UA109804C2 (en) 2-methoxypyridine-4-yl derivatives
WO2011139249A3 (en) Pharmaceutical composition comprising cefdinir
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
TR201010859A2 (en) Tablet forms containing cefdinir.
TR201203083A2 (en) Pharmaceutical dosage form comprising cefdinir and clavulanic acid.
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
TR201203086A2 (en) Pharmaceutical dosage form comprising cefixime and clavulanic acid.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
TR201203087A2 (en) Ceftibutene and clavulanic acid formulations.
TR201203085A2 (en) Compositions containing sefetamet and clavulanic acid.
TR201203084A2 (en) Formulations containing cefditoren pivoxil and clavulanic acid.